Abingdon Health Share Discussion Threads

[tomboyb] 05/4/2022 08:20

Abingdon Health plc

("Abingdon" or "the Company")



Completion of Technical Transfer to full-scale manufacture and initial orders for Vatic KnowNowTM test

Tests manufactured by Abingdon now authorised for sale



York, U.K. 5 April 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces it has successfully completed the technical transfer of the Vatic KnowNowᵀ test (Spike Test in USA) on behalf of its customer, leading diagnostics technology innovator Vatic Health Limited ("Vatic"), on schedule. This follows the conclusion of the scale-up and manufacture of three independent production-scale batches and Vatic has now approved the sale of tests manufactured by Abingdon. Abingdon has received initial purchase orders from Vatic for commercial sale, and manufacturing for these orders will now commence.



The Vatic KnowNowᵀ test is an easy-to-use saliva COVID-19 antigen test, which is the only test that identifies the virus by mimicking the surface of a human cell. This means the test only identifies "live" or "active" copies of the virus which are capable of cell entry and thereby infecting a human cell. Other tests, such as PCR and lateral flow antigen tests, can pick up harmless viral fragments with the potential for users to test positive once they are no longer infectious. Furthermore, the unique detection mechanism of the KnowNowᵀ test has been purposefully designed to be more robust to mutation than traditional antigen tests, making it more future-proofed for ongoing COVID-19 testing. Vatic have previously announced that this test detects variants of the SARS-CoV-2 virus including the Omicron variant.



The test is CE marked for professional use and has been submitted by Vatic to the US FDA for Emergency Use Approval (EUA).



Alex Sheppard, CEO of Vatic Health Limited, commented:

"We are excited to have concluded the transfer of our product to manufacture with Abingdon and to commence sales of our product. Our proprietary technology allows ease of use via a saliva specimen and only detects active virus -enabling individuals to know their infectivity status."



Dr Mona K. Omir, CTO of Vatic Health Limited, commented:

"Completing the Technical Transfer of the KnowNow test is a huge milestone in the Vatic Health journey and our ongoing collaboration with Abingdon Health. To bring such novel assay technology into routine manufacturing could be a true step change in diagnostics and we are excited for what this could mean for COVID-19 testing around the world."



Chris Yates, CEO of Abingdon Health plc, commented:

"We are delighted to have concluded this technical transfer and to begin manufacture of the product for Vatic at our Yorkshire facilities. This is an important addition to the COVID-19 testing toolbox and we look forward to continuing to work with Vatic as we manufacture the product to fulfil their requirements."

[bigjock36] 05/4/2022 07:45

Stick that in your pipe shallow pockets Solid rns confirming TT complete Once Eua is approved and the crooked government pay what they are due this is easy 20 pence per share Great opportunity from here

[74tom] 02/4/2022 10:26

Always starts to pique my interest when a shorter appears to have a ‘god’ complex…

We saw a major short squeeze here last August from 27-85p and saw a number of smaller pops up to the long term downtrend line along the way.

The mid March bounce to 16p took ABDX clear of the downtrend resistance that had been in place since Dec 2020, which like it or not is a bullish sign.

Some other points;

- No, they didn’t wait as long as possible to release their final results, they have until 30th June (6 months post year end) - many examples of companies yet to report - SNG, AVCT being two off the top of my head.

- Yesterdays £50m ONT settlement shows DHSC were waiting until the new budget year to settle the disputes, so there is now a real prospect of getting the £8.4m + 8% interest on the overdue amounts…

- You seem to think this is priced in, I’d argue that 99% of day traders will have forgotten this exists and last remember it being in the 30/40/50p range so will pile in on the news, similar to recent 100/200% moves we’ve seen in AVCT & GDR, and cause a major spike. Also a stock that has had a short squeeze once is far more likely to have a second, especially from a lower level (traders that did well then will look to repeat the trick…)

The place to short would then be the top of said spike… being short now is just asking for a margin call.

[shallow pockets] 29/3/2022 13:23

An awful set of interim results (note how they delayed releasing them to the last poasible minute), no update on any prospect of getting any money from the DHSC, and we just can't see any products in their pipeline, contractual or otherwise, that have any semblance of the necessary high volume sales potential to turn this company around. This stock is about to tip over and fall and fall and.... fall. 4p target remains.

[buywell3] 29/3/2022 07:27

Will the poor results

Get offset by the slew of RNS's about MOU's ?

FDA approval can take years

[shallow pockets] 21/3/2022 09:11

Tick Tock.....the likes of Bigjock36 want to believe in hope but not evidence, even as whispers in the wind of takeovers and contested payments drift away. The evidence is that there is still no line of sight on any DHSC payment, even in part/at a discount. There is no product on the books that has any volume potential. Management evidences no strategy or vision other than talking about runways of opex dissipation of shareholder capital. The financials are due no later than mid week next week. Prepare to hammer the stock. Target is 4p. Any buyers of this company won't look beyond the cash at hand which is lessening each week. It's almost time for another wave to the downside, taking all longs with it.

[bigjock36] 16/3/2022 21:08

Shallow I suggest you read the Vatic update today stating they have applied for fda approval two weeks agoYou sit and stalk this board talking nonsense Anyway lets see who is right and wrong but I can see a nice rise soon My 8p buy is looking very good

[shallow pockets] 16/3/2022 15:46

Probably not ramnik007. There is probably some news out soon re the DHSC paying out something, but probably not all, of what it owes. Then what? The operating pathway gets extended but it still leads in one direction....over a cliff. Not least, the share price has only been above fair value (4p) because part of the market had priced in this payment previously. This rally is now soaking up a lot of buying and short covering and has stalled at what was previously considered an impossibly low price of 15p. The next few days will be a classic market example of selling the good news when it is announced. We are in a (long) queue to hammer this stock hard at that time all the way down to 4p as soon as the news is announced. Be ready.

[9degrees] 15/3/2022 10:03

could they work with the new owners of Omegas Alva factory

[ramnik007] 15/3/2022 09:23

Perhaps Avacta and Abdx have found a way to produce Affimer based, and more accurate LFT. Interesting both rising in synch!

[bigjock36] 14/3/2022 21:21

Shallow pockets you are incorrect Vatic TT is due in March with orders They only recently tweeted this is still on trackClose your short I repeat close your short

[glasswala] 14/3/2022 14:55

A fundraise no doubt to mug the punters once again. This is time tested method by mms to lull people to buy in and then slam in a fundraise and then dropping it like stone in a deep well.Talk about corruption and lining your own grubby pockets the Brits made up the phrase so must be master of it.

[mick1909] 14/3/2022 12:43

Dead cat bounce

[ramnik007] 14/3/2022 12:34

Insiders know something

[megsta] 14/3/2022 12:33

Why is the price increasing?

[innit2] 14/3/2022 10:54

tick tock? up 35% in two trading days, shivers

[bigjock36] 11/3/2022 17:44

Shallow i look forward to TT completing this month for Vatic and your short burning

[shallow pockets] 11/3/2022 09:11

Tick Tock. Tick Tock....can you hear it? It's every minute that passes as management desperately waits to secure the hoped for overdue payment from the DHSC. Financial accounts are due this month. Without any payment, we expect the share price to hit the 4p level. Should a miracle occur, and the DHSC payout happen, even if it is only in part, any share price bounce is to be sold hard. We cannot discover any plan or products or customers of this company that are going to generate any net revenues that turn it from a constant loss maker to profitable or even breakeven. So the current pathway of capital burn and any extension of it funded by the DHSC still leads in only one direction......straight over the cliff edge into the gorge below.. Prepare to reinstate shorts if given the wonderful chance above 12p

[shallow pockets] 08/3/2022 18:07

No dennisbergkamp, it's not about bias. It's about the objective of price efficiency. I am not a "shorter". I am just as happy to be long. But I call it as I see it. Value is the target. Higher or lower. And in this case...its lower still.

[dennisbergkamp] 08/3/2022 17:53

You shorters literally kill lively-hoods, the worse kind of vulture

D

[shallow pockets] 08/3/2022 17:34

We are now more and more stuck BELOW our original target of 8p. We are moving to the sidelines on tonight's close, probably only temporarily , before seeking to reinstate a short with a new target of 3p which we think is fair value and that's IF they get monies owed to them from the Government. If they don't, we think the company goes under. In any event, new top level management is urgently required to build new products and new customers to generate more solid revenues. No matter what the upbeat message from the company later this month, this company has the mark of death written all over it tonight.

[andymunchkin] 03/3/2022 09:31

Average down mug6 Oct '21 - 10:23 - 758 of 1344
0 0 0
48.9 to buy now 🚀🚀🚀🚀8640;🚀Ԇ40;
———;—-
AveraGeDoon cnT😂😂;😂